查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1654227

医学写作人工智慧市场规模、份额、趋势分析报告：按类型、最终用途、地区、细分预测，2025-2030 年

AI In Medical Writing Market Size, Share, & Trends Analysis Report By Type (Clinical Writing, Type Writing), By End-use (Medical Devices, Pharmaceutical), By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10个工作天内

价格

医学写作人工智慧市场的成长和趋势

根据Grand View Research, Inc.的最新报告，全球医学写作人工智慧市场规模预计到2030年将达到17.6002亿美元，2025年至2030年期间的复合年增长率为12.52%。

推动市场扩张的一个主要因素是医疗保健产业对人工智慧（AI）等机器学习的接受度日益提高。此外，降低医疗保健成本的需求不断增长以及製药公司为降低成本而增加研发投资也在推动市场成长。新冠肺炎疫情对市场的影响正逐渐显现。疫情导致研发活动和临床试验停顿。

此外，预算限制导致许多製药公司削减投资。在疫情初期，医学日誌的投稿量也有所下降，对市场成长产生了负面影响。然而，在 COVID-19 疫情期间，企业、研究团体和政府机构在开发创新治疗方法方面的合作努力的价值已经得到证实。因此，医疗设备、生物技术和生命科学公司打算增加对医学作家的投资。因此，在 COVID-19 疫情期间，医疗保健产业对 AI 的需求正在增加。

医学写作人工智慧市场报告重点

  • 由于需要向当局提交监管文件，打字部分占据市场主导地位，占 2024 年总收入的 32.89%。这导致该领域对医学写作人工智慧的需求增加。
  • 根据最终用途，製药业占据市场主导地位，2024 年的收益占有率为 33.33%。
  • 这一高份额归因于对新药和新治疗方法研发活动的大量投资，从而推动了这一终端使用领域对医学写作人工智慧的需求。
  • 2024 年，北美将以 30.12% 的收益占有率占据市场主导地位。这是由于技术不断进步、医疗基础设施不断增加以及药物临床测试和核准的数量不断增加。

目录

第一章调查方法与范围

第 2 章执行摘要

3. 医学写作中的人工智慧市场变数、趋势和范围

  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
    • 市场机会
  • 医学写作中的人工智慧市场分析工具
    • 产业分析 – 波特五力分析
    • PESTEL 分析
    • COVID-19影响分析
    • 案例研究

第 4 章 医学写作市场中的人工智慧：按类型进行的估计和趋势分析

  • 2024 年及 2030 年各类型市场占有率
  • 细分仪表板
  • 全球医学写作人工智慧市场展望（按产品类型）
  • 临床写作
  • 科学写作
  • 打字
  • 其他的

第 5 章 医学写作市场中的人工智慧：按最终用途进行的估计和趋势分析

  • 2024 年及 2030 年终端用途市场占有率
  • 细分仪表板
  • 全球医学写作人工智慧市场前景（按最终用途划分）
  • 医疗设备
  • 药品
  • 生物技术
  • 其他的

第 6 章 医学写作市场中的人工智慧：按产品、类型和最终用途进行的区域估计和趋势分析

  • 2024 年及 2030 年区域市场占有率分析
  • 区域市场仪表板
  • 全球区域市场概况
  • 2018-2030 年市场规模及预测趋势分析
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 挪威
    • 瑞典
    • 丹麦
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 韩国
    • 泰国
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第七章 竞争格局

  • 主要市场参与企业的近期趋势和影响分析
  • 公司/竞争对手分类
  • 2024 年主要企业的市场占有率/地位分析
  • 公司简介
    • Parexel International（MA）Corporation
    • Trilogy Writing &Consulting GmbH
    • Freyr
    • Cactus Communications
    • GENINVO
    • IQVIA Inc.
    • ICON plc
    • Syneos Health
    • IBM
    • Teladoc Health, Inc.
    • SmarterDx
    • Abridge Al, Inc.
    • Suki AI, Inc.
    • Movano
    • Heidi
    • Corti
    • Tortus AI.
    • Nabla Technologies
Product Code: GVR-4-68040-097-9

AI In Medical Writing Market Growth & Trends:

The global AI in medical writing market size is anticipated to reach USD 1,760.02 million by 2030, registering a CAGR of 12.52% from 2025 to 2030, according to a new report by Grand View Research, Inc. The primary factor driving the market expansion is the growing acceptance of machine learning, such as Artificial Intelligence(AI), in the healthcare industry. Moreover, the rising demand for reducing healthcare expenditures and increasing R&D investments by pharmaceutical companies to reduce expenses are other factors that are propelling market growth. The COVID-19 pandemic had affected the market moderately. The pandemic caused a pause in research and development activities as well as clinical trials.

Moreover, budgetary limitations led many pharmaceutical companies to reduce their investments. The initial stages of the pandemic also resulted in a decrease in submissions to healthcare journals, negatively impacting market growth. However, the significance of collaborative efforts between companies, research groups, and government bodies in the development of innovative therapies was demonstrated during the COVID-19 pandemic. Consequently, medical device, biotechnology, and life science companies have intentions to boost their investment in medical writers. Thus, increasing the demand for AI in the healthcare industry during the COVID-19 pandemic.

AI In Medical Writing Market Report Highlights:

  • Based on type, the typewriting segment dominated the market with a share of 32.89% of the overall revenue in 2024 due to the necessity of submitting regulatory documents to the authorities. Thus, boosting the demand for AI in medical writing in this segment
  • Based on end-use, the pharmaceutical segment dominated the market with a revenue share of 33.33% in 2024.
  • The high share was attributed to the heavy investments in R&D activities to develop new drugs and treatments, which augmented the demand for AI in medical writing in this end-use segment
  • In 2024, North America dominated the market with a revenue share of 30.12% owing to the continuous technological advancements, increasing healthcare infrastructure, and a high number of drug trials & their approvals

Table of Contents

Chapter 1. Research Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Type
    • 1.1.2. End Use
    • 1.1.3. Regional scope
    • 1.1.4. Estimates and forecast timeline.
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database.
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
    • 1.6.1. Commodity flow analysis (Model 1)
    • 1.6.2. Approach 1: Commodity flow approach
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Type outlook
    • 2.2.2. End use outlook
    • 2.2.3. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. AI in Medical Writing Market Variables, Trends & Scope

  • 3.1. Market Dynamics
    • 3.1.1. Market driver analysis
    • 3.1.2. Market restraint analysis
    • 3.1.3. Market Opportunities
  • 3.2. AI in Medical Writing Market Analysis Tools
    • 3.2.1. Industry Analysis - Porter's
      • 3.2.1.1. Supplier power
      • 3.2.1.2. Buyer power
      • 3.2.1.3. Substitution threat
      • 3.2.1.4. Threat of new entrant
      • 3.2.1.5. Competitive rivalry
    • 3.2.2. PESTEL Analysis
      • 3.2.2.1. Political landscape
      • 3.2.2.2. Economic landscape
      • 3.2.2.3. Social landscape
      • 3.2.2.4. Technological landscape
      • 3.2.2.5. Environmental landscape
      • 3.2.2.6. Legal landscape
    • 3.2.3. COVID-19 Impact Analysis
    • 3.2.4. Case Studies

Chapter 4. AI in Medical Writing Market: Type Estimates & Trend Analysis

  • 4.1. Type Market Share, 2024 & 2030
  • 4.2. Segment Dashboard
  • 4.3. Global AI in Medical Writing Market by Product Type Outlook
  • 4.4. Clinical Writing
    • 4.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
  • 4.5. Scientific Writing
    • 4.5.1. Market estimates and forecast 2018 to 2030 (USD Million)
  • 4.6. Type Writing
    • 4.6.1. Market estimates and forecast 2018 to 2030 (USD Million)
  • 4.7. Others
    • 4.7.1. Market estimates and forecast 2018 to 2030 (USD Million)

Chapter 5. AI in Medical Writing Market: End Use Estimates & Trend Analysis

  • 5.1. End Use Market Share, 2024 & 2030
  • 5.2. Segment Dashboard
  • 5.3. Global AI in Medical Writing Market by End Use Outlook
  • 5.4. Medical Devices
    • 5.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
  • 5.5. Pharmaceutical
    • 5.5.1. Market estimates and forecast 2018 to 2030 (USD Million)
  • 5.6. Biotechnology
    • 5.6.1. Market estimates and forecast 2018 to 2030 (USD Million)
  • 5.7. Others
    • 5.7.1. Market estimates and forecast 2018 to 2030 (USD Million)

Chapter 6. AI in Medical Writing Market: Regional Estimates & Trend Analysis, By Product, By Type, By End Use

  • 6.1. Regional Market Share Analysis, 2024 & 2030
  • 6.2. Regional Market Dashboard
  • 6.3. Global Regional Market Snapshot
  • 6.4. Market Size & Forecasts Trend Analysis, 2018 to 2030:
  • 6.5. North America
    • 6.5.1. U.S.
      • 6.5.1.1. Key country dynamics
      • 6.5.1.2. Regulatory framework/ reimbursement structure
      • 6.5.1.3. Competitive scenario
      • 6.5.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.5.2. Canada
      • 6.5.2.1. Key country dynamics
      • 6.5.2.2. Regulatory framework/ reimbursement structure
      • 6.5.2.3. Competitive scenario
      • 6.5.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.5.3. Mexico
      • 6.5.3.1. Key country dynamics
      • 6.5.3.2. Regulatory framework/ reimbursement structure
      • 6.5.3.3. Competitive scenario
      • 6.5.3.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.6. Europe
    • 6.6.1. UK
      • 6.6.1.1. Key country dynamics
      • 6.6.1.2. Regulatory framework/ reimbursement structure
      • 6.6.1.3. Competitive scenario
      • 6.6.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.2. Germany
      • 6.6.2.1. Key country dynamics
      • 6.6.2.2. Regulatory framework/ reimbursement structure
      • 6.6.2.3. Competitive scenario
      • 6.6.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.3. France
      • 6.6.3.1. Key country dynamics
      • 6.6.3.2. Regulatory framework/ reimbursement structure
      • 6.6.3.3. Competitive scenario
      • 6.6.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.4. Italy
      • 6.6.4.1. Key country dynamics
      • 6.6.4.2. Regulatory framework/ reimbursement structure
      • 6.6.4.3. Competitive scenario
      • 6.6.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.5. Spain
      • 6.6.5.1. Key country dynamics
      • 6.6.5.2. Regulatory framework/ reimbursement structure
      • 6.6.5.3. Competitive scenario
      • 6.6.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.6. Norway
      • 6.6.6.1. Key country dynamics
      • 6.6.6.2. Regulatory framework/ reimbursement structure
      • 6.6.6.3. Competitive scenario
      • 6.6.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.7. Sweden
      • 6.6.7.1. Key country dynamics
      • 6.6.7.2. Regulatory framework/ reimbursement structure
      • 6.6.7.3. Competitive scenario
      • 6.6.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.8. Denmark
      • 6.6.8.1. Key country dynamics
      • 6.6.8.2. Regulatory framework/ reimbursement structure
      • 6.6.8.3. Competitive scenario
      • 6.6.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.7. Asia Pacific
    • 6.7.1. Japan
      • 6.7.1.1. Key country dynamics
      • 6.7.1.2. Regulatory framework/ reimbursement structure
      • 6.7.1.3. Competitive scenario
      • 6.7.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.7.2. China
      • 6.7.2.1. Key country dynamics
      • 6.7.2.2. Regulatory framework/ reimbursement structure
      • 6.7.2.3. Competitive scenario
      • 6.7.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.7.3. India
      • 6.7.3.1. Key country dynamics
      • 6.7.3.2. Regulatory framework/ reimbursement structure
      • 6.7.3.3. Competitive scenario
      • 6.7.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.7.4. Australia
      • 6.7.4.1. Key country dynamics
      • 6.7.4.2. Regulatory framework/ reimbursement structure
      • 6.7.4.3. Competitive scenario
      • 6.7.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.7.5. South Korea
      • 6.7.5.1. Key country dynamics
      • 6.7.5.2. Regulatory framework/ reimbursement structure
      • 6.7.5.3. Competitive scenario
      • 6.7.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.7.6. Thailand
      • 6.7.6.1. Key country dynamics
      • 6.7.6.2. Regulatory framework/ reimbursement structure
      • 6.7.6.3. Competitive scenario
      • 6.7.6.4. Singapore market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.8. Latin America
    • 6.8.1. Brazil
      • 6.8.1.1. Key country dynamics
      • 6.8.1.2. Regulatory framework/ reimbursement structure
      • 6.8.1.3. Competitive scenario
      • 6.8.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.8.2. Argentina
      • 6.8.2.1. Key country dynamics
      • 6.8.2.2. Regulatory framework/ reimbursement structure
      • 6.8.2.3. Competitive scenario
      • 6.8.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.9. MEA
    • 6.9.1. South Africa
      • 6.9.1.1. Key country dynamics
      • 6.9.1.2. Regulatory framework/ reimbursement structure
      • 6.9.1.3. Competitive scenario
      • 6.9.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.9.2. Saudi Arabia
      • 6.9.2.1. Key country dynamics
      • 6.9.2.2. Regulatory framework/ reimbursement structure
      • 6.9.2.3. Competitive scenario
      • 6.9.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.9.3. UAE
      • 6.9.3.1. Key country dynamics
      • 6.9.3.2. Regulatory framework/ reimbursement structure
      • 6.9.3.3. Competitive scenario
      • 6.9.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.9.4. Kuwait
      • 6.9.4.1. Key country dynamics
      • 6.9.4.2. Regulatory framework/ reimbursement structure
      • 6.9.4.3. Competitive scenario
      • 6.9.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 7.2. Company/Competition Categorization
  • 7.3. Key company market share/position analysis, 2024
  • 7.4. Company Profiles
    • 7.4.1. Parexel International (MA) Corporation.
      • 7.4.1.1. Company overview
      • 7.4.1.2. Financial performance
      • 7.4.1.3. Technology Type benchmarking
      • 7.4.1.4. Strategic initiatives
    • 7.4.2. Trilogy Writing & Consulting GmbH
      • 7.4.2.1. Company overview
      • 7.4.2.2. Financial performance
      • 7.4.2.3. Technology Type benchmarking
      • 7.4.2.4. Strategic initiatives
    • 7.4.3. Freyr
      • 7.4.3.1. Company overview
      • 7.4.3.2. Financial performance
      • 7.4.3.3. Technology Type benchmarking
      • 7.4.3.4. Strategic initiatives
    • 7.4.4. Cactus Communications
      • 7.4.4.1. Company overview
      • 7.4.4.2. Financial performance
      • 7.4.4.3. Technology Type benchmarking
      • 7.4.4.4. Strategic initiatives
    • 7.4.5. GENINVO
      • 7.4.5.1. Company overview
      • 7.4.5.2. Financial performance
      • 7.4.5.3. Technology Type benchmarking
      • 7.4.5.4. Strategic initiatives
    • 7.4.6. IQVIA Inc.
      • 7.4.6.1. Company overview
      • 7.4.6.2. Financial performance
      • 7.4.6.3. Technology Type benchmarking
      • 7.4.6.4. Strategic initiatives
    • 7.4.7. ICON plc
      • 7.4.7.1. Company overview
      • 7.4.7.2. Financial performance
      • 7.4.7.3. Technology Type benchmarking
      • 7.4.7.4. Strategic initiatives
    • 7.4.8. Syneos Health
      • 7.4.8.1. Company overview
      • 7.4.8.2. Financial performance
      • 7.4.8.3. Technology Type benchmarking
      • 7.4.8.4. Strategic initiatives
    • 7.4.9. IBM
      • 7.4.9.1. Company overview
      • 7.4.9.2. Financial performance
      • 7.4.9.3. Technology Type benchmarking
      • 7.4.9.4. Strategic initiatives
    • 7.4.10. Teladoc Health, Inc.
      • 7.4.10.1. Company overview
      • 7.4.10.2. Financial performance
      • 7.4.10.3. Technology Type benchmarking
      • 7.4.10.4. Strategic initiatives
    • 7.4.11. SmarterDx
      • 7.4.11.1. Company overview
      • 7.4.11.2. Financial performance
      • 7.4.11.3. Technology Type benchmarking
      • 7.4.11.4. Strategic initiatives
    • 7.4.12. Abridge Al, Inc.
      • 7.4.12.1. Company overview
      • 7.4.12.2. Financial performance
      • 7.4.12.3. Technology Type benchmarking
      • 7.4.12.4. Strategic initiatives
    • 7.4.13. Suki AI, Inc.
      • 7.4.13.1. Company overview
      • 7.4.13.2. Financial performance
      • 7.4.13.3. Technology Type benchmarking
      • 7.4.13.4. Strategic initiatives
    • 7.4.14. Movano
      • 7.4.14.1. Company overview
      • 7.4.14.2. Financial performance
      • 7.4.14.3. Technology Type benchmarking
      • 7.4.14.4. Strategic initiatives
    • 7.4.15. Heidi
      • 7.4.15.1. Company overview
      • 7.4.15.2. Financial performance
      • 7.4.15.3. Technology Type benchmarking
      • 7.4.15.4. Strategic initiatives
    • 7.4.16. Corti
      • 7.4.16.1. Company overview
      • 7.4.16.2. Financial performance
      • 7.4.16.3. Technology Type benchmarking
      • 7.4.16.4. Strategic initiatives
    • 7.4.17. Tortus AI.
      • 7.4.17.1. Company overview
      • 7.4.17.2. Financial performance
      • 7.4.17.3. Technology Type benchmarking
      • 7.4.17.4. Strategic initiatives
    • 7.4.18. Nabla Technologies
      • 7.4.18.1. Company overview
      • 7.4.18.2. Financial performance
      • 7.4.18.3. Technology Type benchmarking
      • 7.4.18.4. Strategic initiatives

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations
  • Table 3 North America AI in medical writing market estimates and forecasts by type, 2018 - 2030 (USD Million)
  • Table 4 North America AI in medical writing market estimates and forecasts by end use, 2018 - 2030 (USD Million)
  • Table 5 U.S. AI in medical writing market estimates and forecasts by type, 2018 - 2030 (USD Million)
  • Table 6 U.S. AI in medical writing market estimates and forecasts by end use, 2018 - 2030 (USD Million)
  • Table 7 Canada AI in medical writing market estimates and forecasts by type, 2018 - 2030 (USD Million)
  • Table 8 Canada AI in medical writing market estimates and forecasts by end use, 2018 - 2030 (USD Million)
  • Table 9 Mexico AI in medical writing market estimates and forecasts by type, 2018 - 2030 (USD Million)
  • Table 10 Mexico AI in medical writing market estimates and forecasts by end use, 2018 - 2030 (USD Million)
  • Table 11 Europe AI in medical writing market estimates and forecasts by type, 2018 - 2030 (USD Million)
  • Table 12 Europe AI in medical writing market estimates and forecasts by end use, 2018 - 2030 (USD Million)
  • Table 13 UK AI in medical writing market estimates and forecasts by type, 2018 - 2030 (USD Million)
  • Table 14 UK AI in medical writing market estimates and forecasts by end use, 2018 - 2030 (USD Million)
  • Table 15 Germany AI in medical writing market estimates and forecasts by type, 2018 - 2030 (USD Million)
  • Table 16 Germany AI in medical writing market estimates and forecasts by end use, 2018 - 2030 (USD Million)
  • Table 17 France AI in medical writing market estimates and forecasts by type, 2018 - 2030 (USD Million)
  • Table 18 France AI in medical writing market estimates and forecasts by end use, 2018 - 2030 (USD Million)
  • Table 19 Italy AI in medical writing market estimates and forecasts by type, 2018 - 2030 (USD Million)
  • Table 20 Italy AI in medical writing market estimates and forecasts by end use, 2018 - 2030 (USD Million)
  • Table 21 Spain AI in medical writing market estimates and forecasts by type, 2018 - 2030 (USD Million)
  • Table 22 Spain AI in medical writing market estimates and forecasts by end use, 2018 - 2030 (USD Million)
  • Table 23 Denmark AI in medical writing market estimates and forecasts by type, 2018 - 2030 (USD Million)
  • Table 24 Denmark AI in medical writing market estimates and forecasts by end use, 2018 - 2030 (USD Million)
  • Table 25 Sweden AI in medical writing market estimates and forecasts by type, 2018 - 2030 (USD Million)
  • Table 26 Sweden AI in medical writing market estimates and forecasts by end use, 2018 - 2030 (USD Million)
  • Table 27 Norway AI in medical writing market estimates and forecasts by type, 2018 - 2030 (USD Million)
  • Table 28 Norway AI in medical writing market estimates and forecasts by end use, 2018 - 2030 (USD Million)
  • Table 29 Asia Pacific AI in medical writing market estimates and forecasts by type, 2018 - 2030 (USD Million)
  • Table 30 Asia Pacific AI in medical writing market estimates and forecasts by end use, 2018 - 2030 (USD Million)
  • Table 31 Japan AI in medical writing market estimates and forecasts by type, 2018 - 2030 (USD Million)
  • Table 32 Japan AI in medical writing market estimates and forecasts by end use, 2018 - 2030 (USD Million)
  • Table 33 China AI in medical writing market estimates and forecasts by type, 2018 - 2030 (USD Million)
  • Table 34 China AI in medical writing market estimates and forecasts by end use, 2018 - 2030 (USD Million)
  • Table 35 India AI in medical writing market estimates and forecasts by type, 2018 - 2030 (USD Million)
  • Table 36 India AI in medical writing market estimates and forecasts by end use, 2018 - 2030 (USD Million)
  • Table 37 Australia AI in medical writing market estimates and forecasts by type, 2018 - 2030 (USD Million)
  • Table 38 Australia AI in medical writing market estimates and forecasts by end use, 2018 - 2030 (USD Million)
  • Table 39 South Korea AI in medical writing market estimates and forecasts by type, 2018 - 2030 (USD Million)
  • Table 40 South Korea AI in medical writing market estimates and forecasts by end use, 2018 - 2030 (USD Million)
  • Table 41 Thailand AI in medical writing market estimates and forecasts by type, 2018 - 2030 (USD Million)
  • Table 42 Thailand AI in medical writing market estimates and forecasts by end use, 2018 - 2030 (USD Million)
  • Table 43 Latin America AI in medical writing market estimates and forecasts by type, 2018 - 2030 (USD Million)
  • Table 44 Latin America AI in medical writing market estimates and forecasts by end use, 2018 - 2030 (USD Million)
  • Table 45 Brazil AI in medical writing market estimates and forecasts by type, 2018 - 2030 (USD Million)
  • Table 46 Brazil AI in medical writing market estimates and forecasts by end use, 2018 - 2030 (USD Million)
  • Table 47 Argentina AI in medical writing market estimates and forecasts by type, 2018 - 2030 (USD Million)
  • Table 48 Argentina AI in medical writing market estimates and forecasts by end use, 2018 - 2030 (USD Million)
  • Table 49 MEA AI in medical writing market estimates and forecasts by type, 2018 - 2030 (USD Million)
  • Table 50 MEA AI in medical writing market estimates and forecasts by end use, 2018 - 2030 (USD Million)
  • Table 51 South Africa AI in medical writing market estimates and forecasts by type, 2018 - 2030 (USD Million)
  • Table 52 South Africa AI in medical writing market estimates and forecasts by end use, 2018 - 2030 (USD Million)
  • Table 53 Saudi Arabia AI in medical writing market estimates and forecasts by type, 2018 - 2030 (USD Million)
  • Table 54 Saudi Arabia AI in medical writing market estimates and forecasts by end use, 2018 - 2030 (USD Million)
  • Table 55 UAE AI in medical writing market estimates and forecasts by type, 2018 - 2030 (USD Million)
  • Table 56 UAE AI in medical writing market estimates and forecasts by end use, 2018 - 2030 (USD Million)
  • Table 57 Kuwait AI in medical writing market estimates and forecasts by type, 2018 - 2030 (USD Million)
  • Table 58 Kuwait AI in medical writing market estimates and forecasts by end use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 AI in Medical Writing market outlook
  • Fig. 9 AI in Medical Writing competitive insights
  • Fig. 10 Parent market outlook
  • Fig. 11 Related/ancillary market outlook
  • Fig. 12 Penetration and growth prospect mapping
  • Fig. 13 Industry value chain analysis
  • Fig. 14 AI in Medical Writing market driver impact
  • Fig. 15 AI in Medical Writing market restraint impact
  • Fig. 16 AI in Medical Writing market strategic initiatives analysis
  • Fig. 17 AI in Medical Writing market: Type analysis
  • Fig. 18 AI in Medical Writing market: Type outlook and key takeaways
  • Fig. 19 Clinical writing market estimates and forecast, 2018 - 2030
  • Fig. 20 Type writing market estimates and forecast, 2018 - 2030
  • Fig. 21 Scientific writing market estimates and forecast, 2018 - 2030
  • Fig. 22 Others market estimates and forecast, 2018 - 2030
  • Fig. 23 AI in Medical Writing market: End use movement analysis
  • Fig. 24 AI in Medical Writing market: End use outlook and key takeaways
  • Fig. 25 Medical device market estimates and forecast, 2018 - 2030
  • Fig. 26 Pharmaceutical market estimates and forecast, 2018 - 2030
  • Fig. 27 Biotechnology market estimates and forecast, 2018 - 2030
  • Fig. 28 Others market estimates and forecast, 2018 - 2030
  • Fig. 29 Global AI in Medical Writing market: Regional movement analysis
  • Fig. 30 Global AI in Medical Writing market: Regional outlook and key takeaways
  • Fig. 31 Global AI in Medical Writing market share and leading players
  • Fig. 32 North America market share and leading players
  • Fig. 33 Europe market share and leading players
  • Fig. 34 Asia Pacific market share and leading players
  • Fig. 35 Latin America market share and leading players
  • Fig. 36 Middle East & Africa market share and leading players
  • Fig. 37 North America: SWOT
  • Fig. 38 Europe SWOT
  • Fig. 39 Asia Pacific SWOT
  • Fig. 40 Latin America SWOT
  • Fig. 41 MEA SWOT
  • Fig. 42 North America market estimates and forecasts, 2018 - 2030
  • Fig. 43 U.S. market estimates and forecasts, 2018 - 2030
  • Fig. 44 Canada market estimates and forecasts, 2018 - 2030
  • Fig. 45 Mexico market estimates and forecasts, 2018 - 2030
  • Fig. 46 Europe market estimates and forecasts, 2018 - 2030
  • Fig. 47 UK market estimates and forecasts, 2018 - 2030
  • Fig. 48 Germany market estimates and forecasts, 2018 - 2030
  • Fig. 49 France market estimates and forecasts, 2018 - 2030
  • Fig. 50 Italy market estimates and forecasts, 2018 - 2030
  • Fig. 51 Spain market estimates and forecasts, 2018 - 2030
  • Fig. 52 Denmark market estimates and forecasts, 2018 - 2030
  • Fig. 53 Sweden market estimates and forecasts, 2018 - 2030
  • Fig. 54 Norway market estimates and forecasts, 2018 - 2030
  • Fig. 55 Asia Pacific market estimates and forecasts, 2018 - 2030
  • Fig. 56 China market estimates and forecasts, 2018 - 2030
  • Fig. 57 Japan market estimates and forecasts, 2018 - 2030
  • Fig. 58 India market estimates and forecasts, 2018 - 2030
  • Fig. 59 Thailand market estimates and forecasts, 2018 - 2030
  • Fig. 60 South Korea market estimates and forecasts, 2018 - 2030
  • Fig. 61 Australia market estimates and forecasts, 2018 - 2030
  • Fig. 62 Latin America market estimates and forecasts, 2018 - 2030
  • Fig. 63 Brazil market estimates and forecasts, 2018 - 2030
  • Fig. 64 Argentina market estimates and forecasts, 2018 - 2030
  • Fig. 65 Middle East and Africa market estimates and forecasts, 2018 - 2030
  • Fig. 66 South Africa market estimates and forecasts, 2018 - 2030
  • Fig. 67 Saudi Arabia market estimates and forecasts, 2018 - 2030
  • Fig. 68 UAE market estimates and forecasts, 2018 - 2030
  • Fig. 69 Kuwait market estimates and forecasts, 2018 - 2030
  • Fig. 70 Market share of key market players- AI in Medical Writing market
  • Fig. 71 Key Company Categorization
  • Fig. 72 Company Market Share/Position Analysis, 2024
  • Fig. 73 Strategic Framework